Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-08 · accession 0001600620-24-000116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-12 | 2024-11-08 | AUPH | Bailey Jeffrey Allen | Dir | M - OptEx | — | +17.9K | 17.9K | New | — |
| D | 2024-11-12 | 2024-11-11 | AUPH | Bailey Jeffrey Allen | Dir | S - Sale+OE | $8.43 | -4,557 | 13.4K | -25% | -$38.4K |
| D | 2024-11-12 | 2024-11-08 | AUPH | Bailey Jeffrey Allen | Dir | M - OptEx | $0.00 | -17.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-08 | M | A | 17,913 | — | 17,913 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2024-11-11 | S | D | 4,557 | $8.43 | 13,356 | D | — | — | (F2) Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs. (F3) The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.37 to $8.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. |
| 3 | Derivative | Restricted Stock Units | 2024-11-08 | M | D | 17,913 | $0.00 | 0 | D | — · — to — | 17,913 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. (F4) The RSUs vested one year from date of grant and have no expiration date. |